InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Dash Barry H, 董事. Director active across 1 company, notably Elite Pharmaceuticals INC. Aggregated, 4 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €7k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 19 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Barry H. Dash is a Board Member at Elite Pharmaceuticals Inc. He plays a key role in overseeing the company's operations and strategic decision-making. With experience in the pharmaceutical sector, he contributes to the strategic direction of Elite Pharmaceuticals, which focuses on developing generic drugs.